Krilogy Financial
UTHR icon

Krilogy Financial’s United Therapeutics UTHR Stock Holding History

Krilogy Financial’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$660K Sell
1,200
-310
-21% -$160K 0.02% 567
2026
Q2 		$818K Sell
1,510
-78
-5% -$43.9K 0.02% 456
2026
Q1 		$922K Sell
1,588
-165
-9% -$82.2K 0.03% 396
2025
Q4 		$830K Buy
1,753
+712
+68% +$332K 0.03% 400
2025
Q3 		$466K Buy
+1,041
New +$350K 0.02% 541

Other funds holding UTHR

AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Livforsakringsbolaget Skandia
Livforsakringsbolaget Skandia Stockholm, Sweden $3.02B AUM 43.19% 1-Year Est. Return
Nepsis Inc
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

Krilogy Financial's UTHR Position: Q3 2026 in Review

Krilogy Financial reduced its United Therapeutics (UTHR) stake by 21% in Q3 2026, selling an estimated $160K and leaving 1,200 shares worth $660K. The position accounts for 0.02% of the portfolio, ranked #567.

Krilogy Financial first reported a position in UTHR in Q3 2025 and has held it in 5 quarters since. The position peaked at $922K in Q1 2026. 158 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Krilogy Financial held 1,200 shares of United Therapeutics worth $660K as of Q3 2026.
  • Krilogy Financial sold 310 United Therapeutics shares in Q3 2026, an estimated $160K.
  • United Therapeutics made up 0.02% of Krilogy Financial's portfolio in Q3 2026, its #567 holding.
  • Krilogy Financial first reported a position in United Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Krilogy Financial's United Therapeutics position peaked at $922K in Q1 2026.
  • 158 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.